Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Gainesville, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Cyclo Therapeutics, Inc. has filed 698 SEC EDGAR filings since 15 May 1996

SEC filing history

Showing 551-575 of 587 matching filings.

Per page
25
Current page
23
10-Q File 000-25466

QUARTERLY REPORT

Filing date
14 Aug 2012
Reporting date
30 Jun 2012
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Jul 2012
Reporting date
11 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-25466

QUARTERLY REPORT

Filing date
21 May 2012
Reporting date
31 Mar 2012
Next action
Verify source filing
NT 10-Q File 000-25466

FORM 10-Q EXTENSION

Filing date
16 May 2012
Reporting date
31 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-25466

CURRENT REPORT

Filing date
16 May 2012
Reporting date
11 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-25466

ANNUAL REPORT

Filing date
16 Mar 2012
Reporting date
31 Dec 2011
Next action
Verify source filing
10-Q/A File 000-25466

FORM 10-Q/A

Filing date
23 Feb 2012
Reporting date
30 Sep 2011
Next action
Verify source filing
10-Q File 000-25466

QUARTERLY REPORT

Filing date
18 Nov 2011
Reporting date
30 Sep 2011
Next action
Verify source filing
NT 10-Q File 000-25466

QUARTERLY EXTENSION FOR THE PERIOD ENDING 09/11

Filing date
14 Nov 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-25466

QUARTERLY REPORT

Filing date
15 Aug 2011
Reporting date
30 Jun 2011
Next action
Verify source filing
10-Q File 000-25466

QUARTERLY REPORT

Filing date
13 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-25466

CURRENT REPORT

Filing date
26 Apr 2011
Reporting date
25 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-25466

ANNUAL REPORT

Filing date
30 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-25466

CURRENT REPORT

Filing date
28 Mar 2011
Reporting date
22 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
28 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
24 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
11 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-25466

QUARTERLY REPORT AMENDMENT

Filing date
02 Feb 2011
Reporting date
30 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-25466

FORM 10-Q/A

Filing date
02 Feb 2011
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-25466

FORM 10-K/A

Filing date
02 Feb 2011
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Dec 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
13 Dec 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .